Highest-materiality recent filing
Sales of $61.9M (+2.5% YoY); gross margin 36.8% (+240 bps); net loss $(0.09)/share vs $(0.14).
Clarus Q4 sales $65.4M, net loss $0.81/share; FY2026 guidance implies recovery
Q4 sales $65.4M (down 8% YoY); net loss $31.3M ($0.81 loss per diluted share) includes $29.9M goodwill impairment.
Clarus Q3 sales up 3% to $69.3M; net loss narrows, adjusted EBITDA rises 15%
Sales $69.3M (+3% YoY); Outdoor -1% to $48.7M, Adventure +16% to $20.7M.
Clarus Q2 net loss widens to $8.4M; sells PIEPS brand for $9.1M
Sales $55.2M, down 2% YoY; Outdoor +1% to $36.7M, Adventure -8% to $18.6M.
Clarus board allows Kanders to increase stake to 32.9%; two directors depart
Kanders (Executive Chairman) can acquire up to 5,940,700 additional shares, raising beneficial ownership from ~17.9% to 32.9% within 24 months.
Q1 sales $60.4M, down 13% YoY; net loss $(0.14) per diluted share; adjusted EBITDA margin (1.3)%.
Clarus Q4 net loss $65.5M; sales down 6.7% to $71.4M; provides FY2025 outlook
Q4 net loss $65.5M ($1.71/diluted share) vs loss of $8.4M ($0.22) YoY; includes $44.8M goodwill impairment and $21M tax valuation allowance.
Clarus and Black Diamond receive grand jury subpoenas from U.S. Attorney over avalanche transmitters
Clarus and subsidiary Black Diamond Equipment received grand jury subpoenas in January 2025 from the U.S. Attorney’s Office for the District of Utah.
Clarus Q3 sales fall 17.5% to $67.1M; lowers FY2024 adjusted EBITDA guidance to ~$8M midpoint
Sales $67.1M, down from $81.3M YoY; net loss $3.2M ($0.08/share) vs loss $1.3M ($0.03/share).
Clarus Q2 sales fall 2% to $56.5M, net loss $5.5M; cuts EBITDA guidance, reviews PIEPS
Q2 sales $56.5M (-2% YoY); net loss $5.5M ($0.14) vs $2.1M loss ($0.06) prior year.
Clarus Q1 loss from continuing ops widens to $6.5M; Adventure sales up 27%
Sales $69.3M vs $70.3M YoY; gross margin 35.9% (adj. 36.9%).
Clarus posts $15.8M full-year continuing ops loss in 2023; sells Precision Sport for $175M
Sale of Precision Sport segment closed Feb 29, 2024 for $175M; expected gain in Q1 2024.
Clarus permits Greenhouse and Kanders to increase stakes to 15% and 26.7% under poison pill waiver
Greenhouse (current ~11.9% owner) approved to acquire up to 15.0% of CLAR common stock within 12 months.
Q4 2023 sales $76.5M (+4% YoY); gross margin 28.9% vs 37.2%; adjusted EBITDA -$3.5M vs +$3.6M; adjusted EPS -$0.07 vs +$0.11.
Clarus closes $175M sale of Precision Sport segment to JDH Capital; pays off all debt
Sale of Sierra Bullets & Barnes Bullets for $175M cash (before ~$742 working capital adjustment) closed Feb 29, 2024.
Clarus Corporation’s (the “Company”) Board of Directors appointed Mr. Roger Werner to serve on the Company’s Board of Directors effective as of March 8, 2024, until the Company’s next Annual Meeting of Stockholders and until his successor is duly elected and qualified.
On January 8, 2024, James E. Walker III notified the Board of Directors of Clarus Corporation (the “Company”) of his resignation as a director of the Company, effective as of January 8, 2024.
Max materiality 0.85 · Median 0.65 · Most common event earnings